Combination therapy using antioxidants and low level laser therapy (LLLT) on noise induced hearing loss (NIHL)

So-Young Chang; Sung Kyu Lim; Min young Lee; Phil-Sang Chung; Jae-Yun Jung; Chung-Ku Rhee M.D.

doi:10.1117/12.2212380

29 February 2016 Combination therapy using antioxidants and low level laser therapy (LLLT) on noise induced hearing loss (NIHL)

So-Young Chang, Sung Kyu Lim, Min young Lee, Phil-Sang Chung, Jae-Yun Jung, Chung-Ku Rhee M.D.

Author Affiliations +

Proceedings Volume 9689, Photonic Therapeutics and Diagnostics XII; 96892I (2016) https://doi.org/10.1117/12.2212380
Event: SPIE BiOS, 2016, San Francisco, California, United States

Abstract

One of the most common factors that cause hearing disorders is noise trauma. Noise is an increasing hazard and it is pervasive, which makes it difficult to take precautions and prevent noise-induced hearing loss (NIHL). The prevalence of hearing loss among factory workers to be 42 %[1]. Ocupational noise induced hearing loss (ONIHL) continues to be a significant occupational hazard. ONIHL is permanent and may cause significant disability, for which there currently exists no cure, but is largely preventable. More than 30 million Americans are potentially exposed to hazardous noise levels in occupations such as transportation, construction, and coal mining, as well as recreationally. In the mainstream setting, exposure avoidance strategies aimed to reduce the incidence of ONIHL remain the focus of public health and occupational medicine approaches[2]. In military conditions this is most often caused by such things as explosions, blasts, or loud noises from vehicles ranging from 100 to 140 dB[3] and military weapons generating approximately 140–185 dB peak sound pressure levels[4].

Conference Presentation

Citation Download Citation

So-Young Chang, Sung Kyu Lim, Min young Lee, Phil-Sang Chung, Jae-Yun Jung, and Chung-Ku Rhee M.D. "Combination therapy using antioxidants and low level laser therapy (LLLT) on noise induced hearing loss (NIHL)", Proc. SPIE 9689, Photonic Therapeutics and Diagnostics XII, 96892I (29 February 2016); https://doi.org/10.1117/12.2212380

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available